309 / 879
The experience of National Cancer Institute of Milano
The experience of the Fondazione IRCCS Istituto Nazionale dei
Tumori, Milano
2005-2012: 2260 MD clinics
(consultations, second opinions)
•
Improved application of diagnostic/therapeutic guide-lines
- partial or inappropriate therapeutic indications for patients examined in MD
clinics (vs NCCN/EAU): 59%
- wrong prescriptions (vs NCCN/EAU): 11%
•
Histologic reclassification (from low to intermediate risk class): 8%
•
Improved accrual in Active Surveillance protocols
•
Better identification of patients to be enrolled in clinical trials
•
High patients satisfaction
theoric score: 7.5